45940009: Theophylline anhydrous (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with hydrolase inhibitor mechanism of action (substance)\Phosphodiesterase inhibitor\Theophylline anhydrous
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Adenosine receptor antagonist\Theophylline anhydrous

\Drug or medicament (substance)\Respiratory system agent (substance)\...

\Bronchodilator\Theophylline anhydrous

\Methyl xanthine\Theophylline anhydrous

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Purine and/or purine derivative\Xanthine and/or xanthine derivative (substance)\Xanthine derivative (substance)\Methyl xanthine\Theophylline anhydrous

\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Purine and/or purine derivative\Xanthine and/or xanthine derivative (substance)\Xanthine derivative (substance)\Methyl xanthine\Theophylline anhydrous
\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Alkaloid (substance)\Xanthine and/or xanthine derivative (substance)\Xanthine derivative (substance)\Methyl xanthine\Theophylline anhydrous
\Organic compound\Organic nitrogen compound\Purine and/or purine derivative\Xanthine and/or xanthine derivative (substance)\Xanthine derivative (substance)\Methyl xanthine\Theophylline anhydrous

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Theophylline anhydrous	Is a	Product containing theophylline (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Theophylline (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Has disposition	Phosphodiesterase inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Methyl xanthine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Purine derivative diuretic (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Phosphodiesterase inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is modification of (attribute)	Theophylline (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Enzyme inhibitor	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Bronchodilator	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Has disposition	Adenosine receptor antagonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous	Is a	Adenosine receptor antagonist	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Theophylline, anhydrous 80mg/15mL syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 300mg (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 200 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 400 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 450mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline, anhydrous 90mg/150mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Potassium iodide + theophylline, anhydrous 130mg/80mg elixir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 100mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 600mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 100 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 200 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 200 mg oral capsule	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 400 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 400 mg oral capsule	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 400 mg oral tablet	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 50 mg oral capsule	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 200 mg oral tablet	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline, anhydrous 100mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 450mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline anhydrous 300mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 600mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 100 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 200 mg oral capsule	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 400 mg oral capsule	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 400 mg oral tablet	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 50 mg oral capsule	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Theophylline anhydrous 200 mg oral tablet	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Theophylline anhydrous	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
76604013	Theophylline anhydrous	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
783234015	Theophylline anhydrous (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
76604013	Theophylline anhydrous	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
76604013	Theophylline anhydrous	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
783234015	Theophylline anhydrous (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
783234015	Theophylline anhydrous (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core